[Attendance List, World Health Organization Meeting on Scientific and Public Health Rationale for HIV Vaccine Efficacy Trials (1994: Geneva, Switzerland)]

Dr Prasert Thong.harcan, Mahidol Universiry Faculty of Medicine, Siziaj Hospital,
2 Panock Road, Bangkoknoi, Bangkok 10700, Thailand'
Fax: [phone] Tel: [phone]
Dr S. Trip y, Rsearch Fellow, Deparnnent of Cancer Biology, Harvard School of
Public Health 665 Hzmgtington Ave. Boston 02115, USA
Fax: [phone] Tel: [phone]
Dr H. Wipel Director, Swedish Institute for Infectious Disease Co o,
S-10521 Stochohn, Sweden
Fax: 46-8&7303-2-48 Tel: [phone]O0
PHAMCQ'TICAL INDUSRY
The Biocine CPompany, 4560 Horton Street, mrve, CA 9408, USA
Fax: [phone] Tet 510 601 2896
CGeM bh Inci., 460 Point San Brunofoulevard. Sout San Fracio, CA&94080, USA
Fax: [phone] Tel: [phone]
Immuno AG, Indutrtr 67,1221Wien, Austda
Fa= 43 1 20100-550 Tel [phone],0
Pasteur-M6rienx, 3 avenue Pasteur, 3B.10,92430 Macnes-La-Coquette, France
Fa 33 147 0107,99 Teh 33 147,95 80 50
S " Beecham 1330 Rixeart, Belgium
Fa= 32 2 656 8113 Tel: [phone]
Therion Bioloics Corp., 75 Rogers Street; Cambridge, MA 02142-1119, USA
Fax: [phone] Tel' 617 876 7779
WHO Secretari.
Dr M.,. M o Executive Director, GPA
Dr P. M4ioW,&D, RID
Dr J. Espazza. Cief, VAD
Dr S. Osmano, VAD
Dr W. Hey waMd VAD
Dr P. Mai/,Chief, SSB
Dr B. Ferrty, SSB
Dr 1D. Schope, A/Chief, PPC

~a~/paru ~1.

3AV39~a OHMa

A O M9 O T6L g TV004 tT'v1 M 0T/ i1